G-protein-coupled inwardly rectifying potassium channel 4 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

43,351 results for “G-protein-coupled inwardly rectifying potassium channel 4”

Trials

View all 23163 →

Asthma, Inflammation and G Protein-coupled Receptors (GPCR)

205 participants · First posted Nov 19, 2008

Not yet recruiting

The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

160 participants · First posted Apr 21, 2026

Effect of Dietary Oils as G-protein-coupled Receptor Agonists on Glucose Tolerance

10 participants · First posted Dec 12, 2018

Drugs

View all 6512 →

NCC-1566

G protein-coupled receptor 50 antagonists

G-protein coupled receptor antagonists(Proximagen)

Organizations

View all 1745 →

Septerna

United States

A&G Pharmaceutical, Inc.

United States

兆科（广州）肿瘤药物有限公司

News

View all 11931 →

Atrial Fibrillation Pipeline Shows Robust Development with 15+ Novel Therapies from Leading Pharmaceutical Companies

Bayer and Broad Institute Extend Cardiovascular Research Partnership Through 2030

Bayer Launches Global Phase II Trial of GIRK4 Inhibitor BAY 3670549 in Atrial Fibrillation

Page 1 of 4336